HM Payson & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
HM Payson & Co's BSX Position: Q2 2026 in Review
HM Payson & Co increased its Boston Scientific (BSX) stake by 3.1% in Q2 2026, buying an estimated $12.2K and bringing the position to 7,495 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #371.
HM Payson & Co first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $738K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- HM Payson & Co held 7,495 shares of Boston Scientific worth $320K as of Q2 2026.
- HM Payson & Co bought 225 Boston Scientific shares in Q2 2026, an estimated $12.2K.
- Boston Scientific made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #371 holding.
- HM Payson & Co first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
- HM Payson & Co's Boston Scientific position peaked at $738K in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.